These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8585544)

  • 1. Will increases in dose intensity improve outcome: con.
    Souhami RL
    Am J Med; 1995 Dec; 99(6A):71S-76S. PubMed ID: 8585544
    [No Abstract]   [Full Text] [Related]  

  • 2. Will increases in dose intensity improve outcome: pro.
    Hryniuk W
    Am J Med; 1995 Dec; 99(6A):69S-70S. PubMed ID: 8585543
    [No Abstract]   [Full Text] [Related]  

  • 3. Finding the right dose for cancer therapeutics--can we do better?
    Rubin EH; Anderson KM
    Clin Cancer Res; 2010 Feb; 16(4):1085-7. PubMed ID: 20145182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy dose and schedule in adjuvant treatment of breast cancer: phoenix, turkey, or dodo?
    Crown J
    Lancet; 2003 Aug; 362(9385):677-8. PubMed ID: 12957087
    [No Abstract]   [Full Text] [Related]  

  • 5. Will increases in chemotherapy dose intensity improve outcome of patients with common malignancies?
    Tannock I
    Am J Med; 1995 Dec; 99(6A):68S-69S. PubMed ID: 8585542
    [No Abstract]   [Full Text] [Related]  

  • 6. A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: summation dose-intensity.
    Hryniuk W; Frei E; Wright FA
    J Clin Oncol; 1998 Sep; 16(9):3137-47. PubMed ID: 9738586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of hematological growth factors to enable dose intensification in chemotherapy for soft tissue sarcomas.
    Liem GS; Verweij J
    Stem Cells; 1994 Jul; 12(4):402-8. PubMed ID: 7951007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safer cancer chemotherapy using a kinetically-based experimental approach: higher dose intensity with reduced toxicity.
    Price LA
    Cancer Treat Rev; 1987 Dec; 14(3-4):215-23. PubMed ID: 3440249
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose chemotherapy of breast cancer: is the question answered?
    Kennedy MJ
    J Clin Oncol; 1995 Oct; 13(10):2477-9. PubMed ID: 7595695
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytotoxic drugs: the search for dose response.
    Dodwell DJ
    Lancet; 1993 Mar; 341(8845):614-6. PubMed ID: 8094841
    [No Abstract]   [Full Text] [Related]  

  • 11. A network meta-analysis of randomized controlled trials of induction treatments in acute myeloid leukemia in the elderly.
    Ziogas DC; Voulgarelis M; Zintzaras E
    Clin Ther; 2011 Mar; 33(3):254-79. PubMed ID: 21600383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug dosage intensity--a panel discussion.
    McGuire WL; Goldie J; Hryniuk W; Tormey DC
    Breast Cancer Res Treat; 1987; 9(2):87-100. PubMed ID: 3620720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifractionated dosing for cancer chemotherapy: a novel schedule and a work in progress.
    Lokich J
    Cancer Invest; 1999; 17(7):551-4. PubMed ID: 10518201
    [No Abstract]   [Full Text] [Related]  

  • 14. Ovarian cancer: is dose intensity dead?
    Ozols RF
    J Clin Oncol; 2007 Sep; 25(27):4157-8. PubMed ID: 17698802
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms to improve chemotherapy effectiveness.
    Young RC
    Cancer; 1990 Feb; 65(3 Suppl):815-22. PubMed ID: 2406004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-dose chemotherapy: principles, indications and complications].
    Göbel U; Jürgens H; Schwamborn D; Wahn V
    Klin Padiatr; 1988; 200(1):1-6. PubMed ID: 3285085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When less is more.
    Kaiser J
    Science; 2017 Mar; 355(6330):1144-1146. PubMed ID: 28302821
    [No Abstract]   [Full Text] [Related]  

  • 18. Approaches to induction therapy with adult acute myeloid leukaemia.
    Bishop JF
    Acta Haematol; 1998; 99(3):133-7. PubMed ID: 9587394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium.
    Doolittle ND; Anderson CP; Bleyer WA; Cairncross JG; Cloughesy T; Eck SL; Guastadisegni P; Hall WA; Muldoon LL; Patel SJ; Peereboom D; Siegal T; Neuwelt EA
    Neuro Oncol; 2001 Jan; 3(1):46-54. PubMed ID: 11305417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma.
    Meyer RM; Hryniuk WM; Goodyear MD
    J Clin Oncol; 1991 Feb; 9(2):339-47. PubMed ID: 1824863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.